Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons

doi:10.1083/jcb.131.6.1623

This Article

	Full Text (PDF, 1369K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Bennett, K. L.
	Articles by Aruffo, A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Bennett, K. L.
	Articles by Aruffo, A.


Social Bookmarking

	What's this?

ARTICLES

Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons

KL Bennett, B Modrell, B Greenfield, A Bartolazzi, I Stamenkovic, R Peach, DG Jackson, F Spring and A Aruffo
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.

The hyaluronan (HA)-binding function (lectin function) of the leukocyte homing receptor, CD44, is tightly regulated. Herein we address possible mechanisms that regulate CD44 isoform-specific HA binding. Binding studies with melanoma transfectants expressing CD44H, CD44E, or with soluble immunoglobulin fusions of CD44H and CD44E (CD44H-Rg, CD44E-Rg) showed that although both CD44 isoforms can bind HA, CD44H binds HA more efficiently than CD44E. Using CD44-Rg fusion proteins we show that the variably spliced exons in CD44E, V8-V10, specifically reduce the lectin function of CD44, while replacement of V8-V10 by an ICAM-1 immunoglobulin domain restores binding to a level comparable to that of CD44H. Conversely, CD44 bound HA very weakly when exons V8-V10 were replaced with a CD34 mucin domain, which is heavily modified by O- linked glycans. Production of CD44E-Rg or incubation of CD44E- expressing transfectants in the presence of an O-linked glycosylation inhibitor restored HA binding to CD44H-Rg and to cell surface CD44H levels, respectively. We conclude that differential splicing provides a regulatory mechanism for CD44 lectin function and that this effect is due in part to O-linked carbohydrate moieties which are added to the Ser/Thr rich regions encoded by the variably spliced CD44 exons. Alternative splicing resulting in changes in protein glycosylation provide a novel mechanism for the regulation of lectin activity.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Keller, K. E., Kelley, M. J., Acott, T. S. (2007). Extracellular Matrix Gene Alternative Splicing by Trabecular Meshwork Cells in Response to Mechanical Stretching. IOVS 48: 1164-1172 [Abstract] [Full Text]
Rouschop, K. M. A., Sylva, M., Teske, G. J. D., Hoedemaeker, I., Pals, S. T., Weening, J. J., van der Poll, T., Florquin, S. (2006). Urothelial CD44 Facilitates Escherichia coli Infection of the Murine Urinary Tract. J. Immunol. 177: 7225-7232 [Abstract] [Full Text]
Tzircotis, G., Thorne, R. F., Isacke, C. M. (2005). Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. J. Cell Sci. 118: 5119-5128 [Abstract] [Full Text]
Diaz, L. K., Zhou, X., Wright, E. T., Cristofanilli, M., Smith, T., Yang, Y., Sneige, N., Sahin, A., Gilcrease, M. Z. (2005). CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma. Clin. Cancer Res. 11: 3309-3314 [Abstract] [Full Text]
Barbour, A. P., Reeder, J. A., Walsh, M. D., Fawcett, J., Antalis, T. M., Gotley, D. C. (2003). Expression of the CD44v2-10 Isoform Confers a Metastatic Phenotype: Importance of the Heparan Sulfate Attachment Site CD44v3. Cancer Res. 63: 887-892 [Abstract] [Full Text]
Hayes, G. M., Chiu, R., Carpenito, C., Dougherty, S. T., Dougherty, G. J. (2002). Identification of Sequence Motifs Responsible for the Adhesive Interaction between Exon v10-containing CD44 Isoforms. J. Biol. Chem. 277: 50529-50534 [Abstract] [Full Text]
Okamoto, I., Tsuiki, H., Kenyon, L. C., Godwin, A. K., Emlet, D. R., Holgado-Madruga, M., Lanham, I. S., Joynes, C. J., Vo, K. T., Guha, A., Matsumoto, M., Ushio, Y., Saya, H., Wong, A. J. (2002). Proteolytic Cleavage of the CD44 Adhesion Molecule in Multiple Human Tumors. Am. J. Pathol. 160: 441-447 [Abstract] [Full Text]
Nandi, A., Estess, P., Siegelman, M. H. (2000). Hyaluronan Anchoring and Regulation on the Surface of Vascular Endothelial Cells Is Mediated through the Functionally Active Form of CD44. J. Biol. Chem. 275: 14939-14948 [Abstract] [Full Text]
Jones, M., Tussey, L., Athanasou, N., Jackson, D. G. (2000). Heparan Sulfate Proteoglycan Isoforms of the CD44 Hyaluronan Receptor Induced in Human Inflammatory Macrophages Can Function as Paracrine Regulators of Fibroblast Growth Factor Action. J. Biol. Chem. 275: 7964-7974 [Abstract] [Full Text]
Katoh, S., Miyagi, T., Taniguchi, H., Matsubara, Y.-i., Kadota, J.-i., Tominaga, A., Kincade, P. W., Matsukura, S., Kohno, S. (1999). Cutting Edge: An Inducible Sialidase Regulates the Hyaluronic Acid Binding Ability of CD44-Bearing Human Monocytes. J. Immunol. 162: 5058-5061 [Abstract] [Full Text]
Banerji, S., Ni, J., Wang, S.-X., Clasper, S., Su, J., Tammi, R., Jones, M., Jackson, D. G. (1999). LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan. JCB 144: 789-801 [Abstract] [Full Text]
Greenfield, B., Wang, W.-C., Marquardt, H., Piepkorn, M., Wolff, E. A., Aruffo, A., Bennett, K. L. (1999). Characterization of the Heparan Sulfate and Chondroitin Sulfate Assembly Sites in CD44. J. Biol. Chem. 274: 2511-2517 [Abstract] [Full Text]
Wolff, E. A., Greenfield, B., Taub, D. D., Murphy, W. J., Bennett, K. L., Aruffo, A. (1999). Generation of Artificial Proteoglycans Containing Glycosaminoglycan-modified CD44. DEMONSTRATION OF THE INTERACTION BETWEEN RANTES AND CHONDROITIN SULFATE. J. Biol. Chem. 274: 2518-2524 [Abstract] [Full Text]
Yu, Q., Stamenkovic, I. (1999). Localization of matrix metalloproteinase 9�to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13: 35-48 [Abstract] [Full Text]
Martegani, M. P., Del Prete, F., Gasbarri, A., Natali, P. G., Bartolazzi, A. (1999). Structural Variability of CD44v Molecules and Reliability of Immunodetection of CD44 Isoforms Using mAbs Specific for CD44 Variant Exon Products. Am. J. Pathol. 154: 291-300 [Abstract] [Full Text]
Tammi, R., MacCallum, D., Hascall, V. C., Pienimaki, J.-P., Hyttinen, M., Tammi, M. (1998). Hyaluronan Bound to CD44 on Keratinocytes Is Displaced by Hyaluronan Decasaccharides and Not Hexasaccharides. J. Biol. Chem. 273: 28878-28888 [Abstract] [Full Text]
Haegel-Kronenberger, H., de la Salle, H., Bohbot, A., Oberling, F., Cazenave, J.-P., Hanau, D. (1998). Adhesive and/or Signaling Functions of CD44 Isoforms in Human Dendritic Cells. J. Immunol. 161: 3902-3911 [Abstract] [Full Text]
Sherman, L., Wainwright, D., Ponta, H., Herrlich, P. (1998). A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb�outgrowth. Genes Dev. 12: 1058-1071 [Abstract] [Full Text]
Skelton, T. P., Zeng, C., Nocks, A., Stamenkovic, I. (1998). Glycosylation Provides Both Stimulatory and Inhibitory Effects on Cell Surface and Soluble CD44 Binding to Hyaluronan. JCB 140: 431-446 [Abstract] [Full Text]
Esford, L., Maiti, A, Bader, S., Tufaro, F, Johnson, P (1998). Analysis of CD44 interactions with hyaluronan in murine L cell fibroblasts deficient in glycosaminoglycan synthesis: a role for chondroitin sulfate. J. Cell Sci. 111: 1021-1029 [Abstract]
Bajorath, J., Greenfield, B., Munro, S. B., Day, A. J., Aruffo, A. (1998). Identification of CD44 Residues Important for Hyaluronan Binding and Delineation of the Binding Site. J. Biol. Chem. 273: 338-343 [Abstract] [Full Text]
Sleeman, J. P., Kondo, K., Moll, J., Ponta, H., Herrlich, P. (1997). Variant Exons v6 and v7 Together Expand the Repertoire of Glycosaminoglycans Bound by CD44. J. Biol. Chem. 272: 31837-31844 [Abstract] [Full Text]
Griffioen, A. W., Coenen, M. J.H., Damen, C. A., Hellwig, S. M.M., H.J. van Weering, D., Vooys, W., Blijham, G. H., Groenewegen, G. (1997). CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells. Blood 90: 1150-1159 [Abstract] [Full Text]
Weiss, J. M., Sleeman, J., Renkl, A. C., Dittmar, H., Termeer, C. C., Taxis, S., Howells, N., Hofmann, M., Kohler, G., Schopf, E., Ponta, H., Herrlich, P., Simon, J. C. (1997). An Essential Role for CD44 Variant Isoforms in Epidermal Langerhans Cell and Blood Dendritic Cell Function. JCB 137: 1137-1147 [Abstract] [Full Text]
Legras, S., Levesque, J.-P., Charrad, R., Morimoto, K., Le Bousse, C., Clay, D., Jasmin, C., Smadja-Joffe, F. (1997). CD44-Mediated Adhesiveness of Human Hematopoietic Progenitors to Hyaluronan Is Modulated by Cytokines. Blood 89: 1905-1914 [Abstract] [Full Text]